Merck Discontinues Substance P Depression Compound After Failed Trial

Merck is abandoning its efforts to develop the substance P antagonist aprepitant (MK-0869) for treatment of depression

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet